Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 1, 2016, Pages 283-286

  Oyoshi, Michiko K ^a   Venturelli, Nicholas ^a   Geha, Raif S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 33; INTERLEUKIN 4; THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE; CYTOKINE RECEPTOR; IFNG PROTEIN, MOUSE; IL1RL1 PROTEIN, MOUSE; IL33 PROTEIN, HUMAN; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; OVALBUMIN; TSLPR PROTEIN, MOUSE;

ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; TH2 CELL; UPREGULATION; VACCINIA VIRUS; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFLAMMATION; KAPOSI VARICELLIFORM ERUPTION; KNOCKOUT MOUSE; MOUSE; PATHOLOGY; PROCEDURES; SKIN; TH1 TH2 BALANCE; VACCINATION; VIROLOGY;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNIZATION; IMMUNOGLOBULINS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-33; INTERLEUKIN-4; KAPOSI VARICELLIFORM ERUPTION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, CYTOKINE; SKIN; TH1-TH2 BALANCE; VACCINATION; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 84955576244     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.12.1304     Document Type: Article

References (10)

1. 1 Engler, R.J., Kenner, J., Leung, D.Y., Smallpox vaccination: Risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 110 (2002), 357–365.
2. 2 Oyoshi, M.K., Elkhal, A., Kumar, L., Scott, J.E., Koduru, S., He, R., et al. Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proc Natl Acad Sci U S A 106 (2009), 14954–14959.
3. 3 Howell, M.D., Gallo, R.L., Boguniewicz, M., Jones, J.F., Wong, C., Streib, J.E., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24 (2006), 341–348.
4. 4 Hammad, H., Lambrecht, B.N., Barrier epithelial cells and the control of type 2 immunity. Immunity 43 (2015), 29–40.
5. 5 He, R., Oyoshi, M.K., Garibyan, L., Kumar, L., Ziegler, S.F., Geha, R.S., TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci U S A 105 (2008), 11875–11880.
6. 6 Morita, H., Arae, K., Unno, H., Toyama, S., Motomura, K., Matsuda, A., et al. IL-25 and IL-33 contribute to development of eosinophilic airway inflammation in epicutaneously antigen-sensitized mice. PLoS One, 10, 2015, e0134226.
7. 7 Paul, W.E., Zhu, J., How are T(H)2-type immune responses initiated and amplified?. Nat Rev Immunol 10 (2010), 225–235.
8. 8 Oyoshi, M.K., Wang, J.Y., Geha, R.S., Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis. J Allergy Clin Immunol 128 (2011), 890–892.e3.
9. 9 Xu, R., Johnson, A.J., Liggitt, D., Bevan, M.J., Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172 (2004), 6265–6271.
10. 10 Gao, P.S., Rafaels, N.M., Mu, D., Hand, T., Murray, T., Boguniewicz, M., et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 125 (2010), 1403–1407.e4.